| 000 | 01792 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250514023752.0 | ||
| 264 | 0 | _c20020315 | |
| 008 | 200203s 0 0 fre d | ||
| 022 | _a0399-8320 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOuraghi, A | |
| 245 | 0 | 0 |
_a[Infliximab therapy for Crohn's disease anoperineal lesions]. _h[electronic resource] |
| 260 |
_bGastroenterologie clinique et biologique _cNov 2001 |
||
| 300 |
_a949-56 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAbscess _xepidemiology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAnus Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFissure in Ano _xdrug therapy |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPerineum |
| 650 | 0 | 4 |
_aRectal Fistula _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
| 700 | 1 | _aNieuviarts, S | |
| 700 | 1 | _aMougenel, J L | |
| 700 | 1 | _aAllez, M | |
| 700 | 1 | _aBarthet, M | |
| 700 | 1 | _aCarbonnel, F | |
| 700 | 1 | _aCosnes, J | |
| 700 | 1 | _aGendre, J P | |
| 700 | 1 | _aFlourié, B | |
| 700 | 1 | _aMeurisse, J J | |
| 700 | 1 | _aQuandalle, P | |
| 700 | 1 | _aErnst, O | |
| 700 | 1 | _aLemann, M | |
| 700 | 1 | _aCortot, A | |
| 700 | 1 | _aModigliani, R | |
| 700 | 1 | _aColombel, J F | |
| 773 | 0 |
_tGastroenterologie clinique et biologique _gvol. 25 _gno. 11 _gp. 949-56 |
|
| 999 |
_c11753701 _d11753701 |
||